Literature DB >> 15164808

Out-of-pocket health-care expenditures among older Americans with cancer.

Kenneth M Langa1, A Mark Fendrick, Michael E Chernew, Mohammed U Kabeto, Kerry L Paisley, James A Hayman.   

Abstract

OBJECTIVE: There is currently limited information regarding the out-of-pocket expenditures (OOPE) for medical care made by elderly individuals with cancer. We sought to quantify OOPE for community-dwelling individuals age 70 or older with: 1) no cancer (No CA), 2) a history of cancer, not undergoing current treatment (CA/No Tx), and 3) a history of cancer, undergoing current treatment (CA/Tx).
METHODS: We used data from the 1995 Asset and Health Dynamics Study, a nationally representative survey of community-dwelling elderly individuals. Respondents identified their cancer status and reported OOPE for the prior 2 years for: 1) hospital and nursing home stays, 2) outpatient services, 3) home care, and 4) prescription medications. Using a multivariable two-part regression model to control for differences in sociodemographics, living situation, functional limitations, comorbid chronic conditions, and insurance coverage, the additional cancer-related OOPE were estimated.
RESULTS: Of the 6370 respondents, 5382 (84%) reported No CA, 812 (13%) reported CA/No Tx, and 176 (3%) reported CA/Tx. The adjusted mean annual OOPE for the No CA, CA/No Tx, and CA/Tx groups were 1210 dollars, 1450 dollars, and 1880 dollars, respectively (P < .01). Prescription medications (1120 dollars per year) and home care services (250 dollars) accounted for most of the additional OOPE associated with cancer treatment. Low-income individuals undergoing cancer treatment spent about 27% of their yearly income on OOPE compared to only 5% of yearly income for high-income individuals with no cancer history (P < .01).
CONCLUSIONS: Cancer treatment in older individuals results in significant OOPE, mainly for prescription medications and home care services. Economic evaluations and public policies aimed at cancer prevention and treatment should take note of the significant OOPE made by older Americans with cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15164808     DOI: 10.1111/j.1524-4733.2004.72334.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  51 in total

Review 1.  A systematic review of large-scale surveys of cancer survivors conducted in North America, 2000-2011.

Authors:  Catherine C Lerro; Kevin D Stein; Tenbroeck Smith; Katherine S Virgo
Journal:  J Cancer Surviv       Date:  2012-03-03       Impact factor: 4.442

2.  Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors.

Authors:  Minjee Lee; Ramzi G Salloum
Journal:  J Cancer Surviv       Date:  2015-11-30       Impact factor: 4.442

3.  'The bills that were coming in…': out of pocket costs during relocation for specialist treatment for haematological malignancies.

Authors:  Pam McGrath
Journal:  Support Care Cancer       Date:  2016-02-04       Impact factor: 3.603

4.  Gender differences in cost-related medication non-adherence among cancer survivors.

Authors:  Minjee Lee; M Mahmud Khan
Journal:  J Cancer Surviv       Date:  2015-09-09       Impact factor: 4.442

5.  Understanding patient perspectives on communication about the cost of cancer care: a review of the literature.

Authors:  Erin W Hofstatter
Journal:  J Oncol Pract       Date:  2010-06-22       Impact factor: 3.840

6.  Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI).

Authors:  Maria Pisu; Andres Azuero; Karen Meneses; Jeffrey Burkhardt; Patrick McNees
Journal:  Breast Cancer Res Treat       Date:  2010-10-26       Impact factor: 4.872

7.  Use of and spending on supportive care medications among Medicare beneficiaries with cancer.

Authors:  Ilene H Zuckerman; Amy J Davidoff; Mujde Z Erten; Bruce Stuart; Thomas Shaffer; J Samantha Dougherty; Candice Yong
Journal:  Support Care Cancer       Date:  2014-08       Impact factor: 3.603

8.  Economic hardship of minority and non-minority cancer survivors 1 year after diagnosis: another long-term effect of cancer?

Authors:  Maria Pisu; Kelly M Kenzik; Robert A Oster; Patricia Drentea; Kimlin T Ashing; Mona Fouad; Michelle Y Martin
Journal:  Cancer       Date:  2015-01-06       Impact factor: 6.860

Review 9.  The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.

Authors:  Nicolas Iragorri; Claire de Oliveira; Natalie Fitzgerald; Beverley Essue
Journal:  Curr Oncol       Date:  2021-03-15       Impact factor: 3.677

10.  Financial toxicity, Part I: a new name for a growing problem.

Authors:  S Yousuf Zafar; Amy P Abernethy
Journal:  Oncology (Williston Park)       Date:  2013-02       Impact factor: 2.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.